BioWorld

Feb. 25, 2002

View Archived Issues

House Wants Information From Other Potential ImClone Partners

WASHINGTON - A House committee has asked seven pharmaceutical companies that negotiated with ImClone Systems Inc. to partner on Erbitux to turn over documentation and research related to those discussions. (BioWorld Today) Read More

Paranoia’ Over FDA Challenges Looms Large After ImClone Woes

Read More

Restoragen Cuts Half Its Staff, Plans To Rework Business Plan

Read More

Immunex’s Enbrel Performs Well In Phase II Psoriasis Trial

Read More

Other News To Note

Read More

Correction

Read More